Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — January 2026

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

Cencora, Inc. (COR)

Mauch Robert P. — Director
Jan 20, 2026
Sale
Shares
5,096
Price
$354.73
Total Value
$1.81M
Shares Held After
66,726
% of Holdings
7.1%

INSMED Inc (INSM)

Lewis William — Director
Jan 20, 2026
Sale
Shares
254
Price
$160.70
Total Value
$40.82K
Shares Held After
306,891
% of Holdings
0.1%

INSMED Inc (INSM)

Lewis William — Director
Jan 20, 2026
Sale
Shares
2,229
Price
$159.85
Total Value
$356.31K
Shares Held After
307,145
% of Holdings
0.7%

INSMED Inc (INSM)

Lewis William — Director
Jan 20, 2026
Sale
Shares
5,967
Price
$158.99
Total Value
$948.69K
Shares Held After
309,374
% of Holdings
1.9%

INSMED Inc (INSM)

Lewis William — Director
Jan 20, 2026
Sale
Shares
1,243
Price
$158.37
Total Value
$196.85K
Shares Held After
315,341
% of Holdings
0.4%

INSMED Inc (INSM)

Lewis William — Director
Jan 20, 2026
Sale
Shares
1,006
Price
$156.80
Total Value
$157.74K
Shares Held After
316,584
% of Holdings
0.3%
Jan 20, 2026
Sale
Shares
4,017
Price
$40.01
Total Value
$160.73K
Shares Held After
87,715
% of Holdings
4.4%

Ginkgo Bioworks Holdings, Inc. (DNA)

Coen Steven P. — Chief Financial Officer
Jan 20, 2026
Sale
Shares
972
Price
$8.92
Total Value
$8.67K
Shares Held After
8,321
% of Holdings
10.5%

NEOGENOMICS INC (NEO)

Stone Warren — Pres & Chief Operating Officer
Jan 20, 2026
Sale
Shares
22,128
Price
$12.50
Total Value
$276.68K
Shares Held After
121,631
% of Holdings
15.4%
Jan 20, 2026
Sale
Shares
10,000
Price
$26.88
Total Value
$268.80K
Shares Held After
727,770
% of Holdings
1.4%
Jan 20, 2026
Sale
Shares
75,000
Price
$7.88
Total Value
$590.93K
Shares Held After
3,091,604
% of Holdings
2.4%
Jan 20, 2026
Sale
Shares
76,967
Price
$6.54
Total Value
$503.36K
Shares Held After
3,166,604
% of Holdings
2.4%
Jan 20, 2026
Sale
Shares
25,000
Price
$7.51
Total Value
$187.65K
Shares Held After
0
% of Holdings
100.0%

Serina Therapeutics, Inc. (SER)

Moreadith Randall — Chief Scientific Officer
Jan 20, 2026
Sale
Shares
2,000
Price
$3.07
Total Value
$6.14K
Shares Held After
0
% of Holdings
100.0%

Outset Medical, Inc. (OM)

Nash Marc — EVP Operations R&D & Service
Jan 20, 2026
Sale
Shares
5,375
Price
$5.12
Total Value
$27.52K
Shares Held After
42,785
% of Holdings
11.2%

Outset Medical, Inc. (OM)

Brottem John L. — General Counsel
Jan 20, 2026
Sale
Shares
9,314
Price
$5.12
Total Value
$47.69K
Shares Held After
36,957
% of Holdings
20.1%

Gemini Therapeutics, Inc. (GMTX)

Khara Rahul — Chief Legal Officer
Jan 20, 2026
Sale
Shares
1,000
Price
$69.74
Total Value
$69.74K
Shares Held After
37,793
% of Holdings
2.6%
Jan 20, 2026
Sale
Shares
11,794
Price
$5.12
Total Value
$60.39K
Shares Held After
107,823
% of Holdings
9.9%

Clene Inc. (CLNN)

Ugwumba Chidozie — 10% Owner
Jan 20, 2026
Sale
Shares
12,432
Price
$4.80
Total Value
$59.67K
Shares Held After
629,943
% of Holdings
1.9%

Protagonist Therapeutics, Inc. (PTGX)

MOLINA ARTURO MD — Chief Medical Officer
Jan 20, 2026
Sale
Shares
9,514
Price
$82.48
Total Value
$784.71K
Shares Held After
97,266
% of Holdings
8.9%
Jan 20, 2026
Sale
Shares
1,689
Price
$2.88
Total Value
$4.87K
Shares Held After
384,216
% of Holdings
0.4%
Jan 20, 2026
Sale
Shares
34,438
Price
$82.48
Total Value
$2.84M
Shares Held After
580,505
% of Holdings
5.6%

Protagonist Therapeutics, Inc. (PTGX)

Ali Asif — Chief Financial Officer
Jan 20, 2026
Sale
Shares
8,588
Price
$82.48
Total Value
$708.34K
Shares Held After
78,077
% of Holdings
9.9%

BioCardia, Inc. (BCDA)

Altman Peter — Director
Jan 20, 2026
Purchase
Shares
600
Price
$1.32
Total Value
$792.00
Shares Held After
268,566
% of Holdings
0.2%
Jan 20, 2026
Sale
Shares
5,000
Price
$123.50
Total Value
$617.50K
Shares Held After
8,920
% of Holdings
35.9%

Hims & Hers Health, Inc. (HIMS)

Okupe Oluyemi — Chief Financial Officer
Jan 20, 2026
Sale
Shares
9,067
Price
$30.34
Total Value
$275.11K
Shares Held After
91,617
% of Holdings
9.0%

Apellis Pharmaceuticals, Inc. (APLS)

Baumal Caroline — Chief Medical Officer
Jan 20, 2026
Sale
Shares
1,882
Price
$19.79
Total Value
$37.25K
Shares Held After
89,324
% of Holdings
2.1%

Apellis Pharmaceuticals, Inc. (APLS)

Chopas James George — VP/Chief Accounting Officer
Jan 20, 2026
Sale
Shares
726
Price
$19.79
Total Value
$14.37K
Shares Held After
51,869
% of Holdings
1.4%

Apellis Pharmaceuticals, Inc. (APLS)

DeLong Mark Jeffrey — Chief Business & Strat Officer
Jan 20, 2026
Sale
Shares
1,334
Price
$19.79
Total Value
$26.40K
Shares Held After
81,724
% of Holdings
1.6%

Apellis Pharmaceuticals, Inc. (APLS)

Deschatelets Pascal — Chief Scientific Officer
Jan 20, 2026
Sale
Shares
909
Price
$19.79
Total Value
$17.99K
Shares Held After
1,157,310
% of Holdings
0.1%
Jan 20, 2026
Sale
Shares
8,182
Price
$19.79
Total Value
$161.95K
Shares Held After
313,237
% of Holdings
2.5%

Apellis Pharmaceuticals, Inc. (APLS)

Nicholson Nur — Chief Technical Officer
Jan 20, 2026
Sale
Shares
2,203
Price
$19.79
Total Value
$43.60K
Shares Held After
78,843
% of Holdings
2.7%

Apellis Pharmaceuticals, Inc. (APLS)

Sullivan Timothy Eugene — Chief Financial Officer
Jan 20, 2026
Sale
Shares
2,892
Price
$19.79
Total Value
$57.24K
Shares Held After
104,188
% of Holdings
2.7%
Jan 20, 2026
Sale
Shares
2,475
Price
$19.79
Total Value
$48.99K
Shares Held After
96,363
% of Holdings
2.5%

Travere Therapeutics, Inc. (TVTX)

REED ELIZABETH E — Chief Legal Officer and GC
Jan 20, 2026
Sale
Shares
10,000
Price
$27.34
Total Value
$273.42K
Shares Held After
90,270
% of Holdings
10.0%

Mirum Pharmaceuticals, Inc. (MIRM)

Quan Joanne — CHIEF MEDICAL OFFICER
Jan 20, 2026
Sale
Shares
6,911
Price
$90.27
Total Value
$623.85K
Shares Held After
11,305
% of Holdings
37.9%

IRADIMED CORP (IRMD)

Susi Roger E. — Director
Jan 20, 2026
Sale
Shares
1,797
Price
$102.70
Total Value
$184.55K
Shares Held After
2,267,500
% of Holdings
0.1%

IRADIMED CORP (IRMD)

Susi Roger E. — Director
Jan 20, 2026
Sale
Shares
1,074
Price
$102.03
Total Value
$109.58K
Shares Held After
2,269,297
% of Holdings
0.0%

IRADIMED CORP (IRMD)

Susi Roger E. — Director
Jan 20, 2026
Sale
Shares
2,129
Price
$101.03
Total Value
$215.09K
Shares Held After
2,270,371
% of Holdings
0.1%

Beam Therapeutics Inc. (BEAM)

Cavanagh Bethany J — SVP, Finance and Treasurer
Jan 20, 2026
Sale
Shares
3,034
Price
$30.12
Total Value
$91.38K
Shares Held After
41,011
% of Holdings
6.9%

IRIDEX CORP (IRIX)

Dizon Romeo R — Chief Financial Officer
Jan 20, 2026
Purchase
Shares
2,100
Price
$1.50
Total Value
$3.15K
Shares Held After
98,281
% of Holdings
2.1%

Mineralys Therapeutics, Inc. (MLYS)

Rodman David Malcom — Chief Medical Officer
Jan 20, 2026
Sale
Shares
416
Price
$32.10
Total Value
$13.35K
Shares Held After
50,437
% of Holdings
0.8%
Jan 20, 2026
Sale
Shares
6,000
Price
$75.00
Total Value
$450.00K
Shares Held After
21,659
% of Holdings
21.7%

Nurix Therapeutics, Inc. (NRIX)

Ring Christine — Chief Legal Officer
Jan 20, 2026
Sale
Shares
3,760
Price
$18.42
Total Value
$69.27K
Shares Held After
50,897
% of Holdings
6.9%
Jan 20, 2026
Purchase
Shares
9,568
Price
$19.60
Total Value
$187.53K
Shares Held After
1,016,658
% of Holdings
0.9%
Jan 20, 2026
Purchase
Shares
8,484
Price
$19.60
Total Value
$166.29K
Shares Held After
900,292
% of Holdings
0.9%

Surrozen, Inc./DE (SRZN)

Kutzkey Tim — Director
Jan 20, 2026
Purchase
Shares
9,568
Price
$19.60
Total Value
$187.53K
Shares Held After
1,016,658
% of Holdings
0.9%

Surrozen, Inc./DE (SRZN)

Kutzkey Tim — Director
Jan 20, 2026
Purchase
Shares
8,484
Price
$19.60
Total Value
$166.29K
Shares Held After
900,292
% of Holdings
0.9%

Aura Biosciences, Inc. (AURA)

Elazzouzi Amy — Senior Vice President, Finance
Jan 20, 2026
Sale
Shares
1,581
Price
$4.86
Total Value
$7.68K
Shares Held After
84,081
% of Holdings
1.8%
Jan 20, 2026
Sale
Shares
16,928
Price
$4.86
Total Value
$82.27K
Shares Held After
457,463
% of Holdings
3.6%
Version: v26.3.26